Evidence map›Paper›PMID 33268789›Full record

ArticleNature communications2020

A human tissue map of 5-hydroxymethylcytosines exhibits tissue specificity through gene and enhancer modulation.

Xiao-Long Cui, Ji Nie, Jeremy Ku, Urszula Dougherty, Diana C West-Szymanski, Francois Collin, Christopher K Ellison, Laura Sieh, Yuhong Ning, Zifeng Deng and 15 more

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 113 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
113citing papers in PubMed, 1 pooled it
12.7field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

113 citing papers in PubMed, 1 synthesis or guideline pooled it, 215 citations in OpenAlex.

  1. Genetic architecture of mammographic density as a risk factor for breast cancer: a systematic review.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2023
    Pooled it
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. MidbrainbioRxiv : the preprint server for biology · 2026
    Article
  10. Article
  11. Article
  12. Article
  13. New Clues to the Challenge of Knee Arthrofibrosis: From Molecules to Therapies.The Journal of the American Academy of Orthopaedic Surgeons · 2026
    Review
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Review
  20. Article

53 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

25 authors at 5 institutions in 1 country.

Xiao-Long CuiDepartment of Chemistry, Department of Biochemistry and Molecular Biology, Institute for Biophysical Dynamics, University of Chicago, Chicago, IL, USA.ORCID 0000-0002-1345-2271
Ji NieDepartment of Chemistry, Department of Biochemistry and Molecular Biology, Institute for Biophysical Dynamics, University of Chicago, Chicago, IL, USA.
Jeremy KuBluestar Genomics Inc., San Diego, CA, USA.
Urszula DoughertyDepartment of Medicine, University of Chicago, Chicago, IL, USA.
Diana C West-SzymanskiHoward Hughes Medical Institute, University of Chicago, Chicago, IL, USA.
Francois CollinBluestar Genomics Inc., San Diego, CA, USA.
Christopher K EllisonBluestar Genomics Inc., San Diego, CA, USA.
Laura SiehDepartment of Chemistry, Department of Biochemistry and Molecular Biology, Institute for Biophysical Dynamics, University of Chicago, Chicago, IL, USA.ORCID 0000-0003-3238-016X
Yuhong NingBluestar Genomics Inc., San Diego, CA, USA.
Zifeng DengDepartment of Medicine, University of Chicago, Chicago, IL, USA.
Carolyn W T ZhaoDepartment of Chemistry, Department of Biochemistry and Molecular Biology, Institute for Biophysical Dynamics, University of Chicago, Chicago, IL, USA.
Anna BergamaschiBluestar Genomics Inc., San Diego, CA, USA.
Joel PekowDepartment of Medicine, University of Chicago, Chicago, IL, USA.
Jiangbo WeiDepartment of Chemistry, Department of Biochemistry and Molecular Biology, Institute for Biophysical Dynamics, University of Chicago, Chicago, IL, USA.ORCID 0000-0003-2691-6490
Alana V BeadellDepartment of Chemistry, Department of Biochemistry and Molecular Biology, Institute for Biophysical Dynamics, University of Chicago, Chicago, IL, USA.
Zhou ZhangDepartment of Preventive Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.ORCID 0000-0002-9639-052X
Geeta SharmaCity of Hope Comprehensive Cancer Center, Duarte, CA, USA.ORCID 0000-0003-4144-2799
Raman TalwarBluestar Genomics Inc., San Diego, CA, USA.
Patrick ArensdorfBluestar Genomics Inc., San Diego, CA, USA.
Jason KarpusDepartment of Chemistry, Department of Biochemistry and Molecular Biology, Institute for Biophysical Dynamics, University of Chicago, Chicago, IL, USA.
Ajay GoelCity of Hope Comprehensive Cancer Center, Duarte, CA, USA.ORCID 0000-0003-1396-6341
Marc BissonnetteDepartment of Medicine, University of Chicago, Chicago, IL, USA.
Wei ZhangDepartment of Preventive Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.ORCID 0000-0003-0875-263X
Samuel LevyBluestar Genomics Inc., San Diego, CA, USA.ORCID 0000-0002-4444-5103
Chuan HeDepartment of Chemistry, Department of Biochemistry and Molecular Biology, Institute for Biophysical Dynamics, University of Chicago, Chicago, IL, USA. chuanhe@uchicago.edu.ORCID 0000-0003-4319-7424
Howard Hughes Medical Institute · USID Genomics (United States) · USUniversity of Chicago · USCity of Hope · USNorthwestern University · US

Funding

ULTRASTRUCTURE AND CYTOMORPHOLOGY COREP30DK042086 · NIDDK · UNIVERSITY OF CHICAGO · PI CHANG, EUGENE B · 1990 to 2025
$29.8M
Labeling and sequencing of 5hmC and 5mC in DNA-RenewalR01HG006827 · NHGRI · UNIVERSITY OF CHICAGO · PI HE, CHUAN · 2012 to 2025
$7.2M
Epigenomic markers of circulating cell-free DNA and treatment outcome in multiple myelomaR01CA223662 · NCI · UNIVERSITY OF CHICAGO · PI CHIU, BRIAN C-H, ZHANG, WEI · 2018 to 2022
$3.2M
Development of 5hmC and 5mC biomarkers in cell-free circulating DNA for sensitive colon cancer detection and prognosisU01CA217078 · NCI · UNIVERSITY OF CHICAGO · PI BISSONNETTE, BRUCE MARC, ZHANG, WEI · 2017 to 2021
$3.2M
Probing short and long term consequences of Small and Large Bowel Microbiota Transplants on Host Physiology: Implications for the development of future live biotherapeuticsR01DK138072 · NIDDK · UNIVERSITY OF CHICAGO · PI EUGENE B CHANG, Kristina Brooke Martinez-Guryn · 2024 to 2026
$2.1M
CXCR4 as a target for colon cancer chemopreventionR01CA240710 · NCI · UNIVERSITY OF CHICAGO · PI BISSONNETTE, BRUCE MARC · 2019 to 2023
$1.8M
Howard Hughes Medical InstituteNCI NIH HHS R01 CA223662NCI NIH HHS R01 CA240710NCI NIH HHS U01 CA217078NHGRI NIH HHS R01 HG006827NIDDK NIH HHS P30 DK042086NIDDK NIH HHS R01 DK138072
6 · The paper itself

Abstract

DNA 5-hydroxymethylcytosine (5hmC) modification is known to be associated with gene transcription and frequently used as a mark to investigate dynamic DNA methylation conversion during mammalian development and in human diseases. However, the lack of genome-wide 5hmC profiles in different human tissue types impedes drawing generalized conclusions about how 5hmC is implicated in transcription activity and tissue specificity. To meet this need, we describe the development of a 5hmC tissue map by characterizing the genomic distributions of 5hmC in 19 human tissues derived from ten organ systems. Subsequent sequencing results enabled the identification of genome-wide 5hmC distributions that uniquely separates samples by tissue type. Further comparison of the 5hmC profiles with transcriptomes and histone modifications revealed that 5hmC is preferentially enriched on tissue-specific gene bodies and enhancers. Taken together, the results provide an extensive 5hmC map across diverse human tissue types that suggests a potential role of 5hmC in tissue-specific development; as well as a resource to facilitate future studies of DNA demethylation in pathogenesis and the development of 5hmC as biomarkers.

Indexed as

Enhancer Elements, GeneticEpigenesis, GeneticGenome, Human5-MethylcytosineChromosome MappingCpG IslandsCytosineDNADNA MethylationHistonesHumansOrgan SpecificityTranscriptional ActivationTranscription Factors5-hydroxymethylcytosine5-MethylcytosineCytosineDNAHistonesTranscription Factors

Identifiers

PMID33268789
PMCPMC7710742
OpenAlexW3108971791

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.